SCHEMBL12864395

SCHEMBL12864395

CC(=O)c1cc2occc2[nH]1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DAO P14920 4/20 0.71
▸ POLB P06746 1/20 0.48
▸ GAA P10253 1/20 0.44
▸ KCNA3 P22001 3/20 0.36
▸ NTRK1 P04629 1/20 0.35
▸ HRH4 Q9H3N8 2/20 0.33
▸ PIN1 Q13526 1/20 0.32
▸ FLT3 P36888 1/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ EGFR P00533 1/20 0.31
▸ PIK3CA P42336 1/20 0.31
▸ CREBBP Q92793 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ SRD5A2 P31213 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ SMYD3 Q9H7B4 1/20 0.31
▸ AKR1C3 P42330 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL679809 0.83 DAO (1.00) DAOPOLBGAAPIN1MEN1
SCHEMBL12864370 0.82 DAO (0.61) DAOPOLBGAAKCNA3NTRK1
SCHEMBL12864422 0.81 DAO (0.71) DAOPOLBGAANTRK1FLT3
SCHEMBL1171052 0.81 DAO (0.71) DAOPOLBGAANTRK1FLT3
SCHEMBL1171650 0.81 DAO (0.96) DAOPOLBGAAPIN1MEN1
SCHEMBL1171400 0.81 DAO (0.71) DAOPOLBGAANTRK1FLT3
SCHEMBL989408 0.81 DAO (0.65) DAOPOLBGAACREBBPKDM4E
SCHEMBL12864593 0.81 DAO (0.65) DAOPOLBGAANTRK1KDM4E
SCHEMBL12864371 0.80 DAO (0.69) DAOPOLBGAANTRK1FLT3
SCHEMBL12904066 0.79 DAO (0.67) DAOPOLBGAANTRK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110034434-A1 PRODRUGS OF FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2011-02-10 — — US disclosed
US-20110034434-A1 PRODRUGS OF FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2011-02-10 — — US disclosed
US-20100120740-A1 PRODRUGS OF FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-05-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120740-A1 PRODRUGS OF FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE DDO, DAO, AOC1 DAO 2/4885POLB 2437/4885GAA 1237/4885
US-20110034434-A1 PRODRUGS OF FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE DDO, DAO, AOC1 DAO 2/4885POLB 2437/4885GAA 1237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback